Conference Proceedings
IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) chemotherapy
S Peters, AW Kim, B Solomon, DR Gandara, R Dziadziuszko, A Brunelli, MC Garassino, M Reck, L Wang, I To, SW Sun, BJ Gitlitz, A Sandler, N Rizvi
Annals of oncology : official journal of the European Society for Medical Oncology | OXFORD UNIV PRESS | Published : 2019
Grants
Funding Acknowledgements
F. Hoffmann-La Roche, Ltd.